“As a one-hour point-of-care test, the Spartan RX CYP2C19 has the potential to significantly reduce major cardiac events in heart attack patients. ”
Dr. Derek So, M.D.
Staff cardiologist
University of Ottawa Heart Institute
NEW:
• Visit our booth at upcoming tradeshows.
• Spartan Bioscience announces CE marking
for the Spartan RX CYP2C19.
